Response to Dawson et al: Letter to the Editor on ''A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK''.

Saved in:
Bibliographic Details
Title: Response to Dawson et al: Letter to the Editor on ''A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK''.
Authors: Vyse A; Medical Affairs, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK., Campling J; Medical Affairs, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK., Czudek C; Medical Affairs, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK., Ellsbury G; Medical Affairs, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK., Mendes D; Health & Value, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK., Reinert RR; Medical Affairs, Pfizer Inc, Paris, France., Slack MPE; School of Medicine & Dentistry, Griffith University, Gold Coast Campus, Queensland 4222, Australia.
Source: Expert review of vaccines [Expert Rev Vaccines] 2022 Jun; Vol. 21 (6), pp. 871-872. Date of Electronic Publication: 2022 Mar 08.
Publication Type: Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101155475 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8395 (Electronic) Linking ISSN: 14760584 NLM ISO Abbreviation: Expert Rev Vaccines Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35226814
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Response to Dawson et al: Letter to the Editor on ''A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK''.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vyse+A%22">Vyse A</searchLink>; Medical Affairs, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK.<br /><searchLink fieldCode="AU" term="%22Campling+J%22">Campling J</searchLink>; Medical Affairs, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK.<br /><searchLink fieldCode="AU" term="%22Czudek+C%22">Czudek C</searchLink>; Medical Affairs, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK.<br /><searchLink fieldCode="AU" term="%22Ellsbury+G%22">Ellsbury G</searchLink>; Medical Affairs, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK.<br /><searchLink fieldCode="AU" term="%22Mendes+D%22">Mendes D</searchLink>; Health & Value, Pfizer Ltd, Walton Oaks, Tadworth, KT20 7NS, UK.<br /><searchLink fieldCode="AU" term="%22Reinert+RR%22">Reinert RR</searchLink>; Medical Affairs, Pfizer Inc, Paris, France.<br /><searchLink fieldCode="AU" term="%22Slack+MPE%22">Slack MPE</searchLink>; School of Medicine & Dentistry, Griffith University, Gold Coast Campus, Queensland 4222, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101155475%22">Expert review of vaccines</searchLink> [Expert Rev Vaccines] 2022 Jun; Vol. 21 (6), pp. 871-872. <i>Date of Electronic Publication: </i>2022 Mar 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101155475 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8395 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214760584%22">14760584 </searchLink><i>NLM ISO Abbreviation: </i>Expert Rev Vaccines <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35226814
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14760584.2022.2047024
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 871
    Titles:
      – TitleFull: Response to Dawson et al: Letter to the Editor on ''A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK''.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vyse A
      – PersonEntity:
          Name:
            NameFull: Campling J
      – PersonEntity:
          Name:
            NameFull: Czudek C
      – PersonEntity:
          Name:
            NameFull: Ellsbury G
      – PersonEntity:
          Name:
            NameFull: Mendes D
      – PersonEntity:
          Name:
            NameFull: Reinert RR
      – PersonEntity:
          Name:
            NameFull: Slack MPE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2022 Jun
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8395
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Expert review of vaccines
              Type: main
ResultId 1